- Home
- INZY vs FUNC Comparison
INZY vs FUNC Comparison
Compare INZY & FUNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INZY
- FUNC
- Stock Information
- Founded
- INZY 2015
- FUNC 1900
- Country
- INZY United States
- FUNC United States
- Employees
- INZY N/A
- FUNC N/A
- Industry
- INZY Biotechnology: Pharmaceutical Preparations
- FUNC Major Banks
- Sector
- INZY Health Care
- FUNC Finance
- Exchange
- INZY Nasdaq
- FUNC Nasdaq
- Market Cap
- INZY 188.2M
- FUNC 223.8M
- IPO Year
- INZY 2020
- FUNC N/A
- Fundamental
- Price
- INZY $1.36
- FUNC $32.95
- Analyst Decision
- INZY Strong Buy
- FUNC
- Analyst Count
- INZY 8
- FUNC 0
- Target Price
- INZY $17.75
- FUNC N/A
- AVG Volume (30 Days)
- INZY 784.0K
- FUNC 31.6K
- Earning Date
- INZY 03-11-2025
- FUNC 02-03-2025
- Dividend Yield
- INZY N/A
- FUNC 2.67%
- EPS Growth
- INZY N/A
- FUNC N/A
- EPS
- INZY N/A
- FUNC 2.45
- Revenue
- INZY N/A
- FUNC $71,027,000.00
- Revenue This Year
- INZY N/A
- FUNC N/A
- Revenue Next Year
- INZY N/A
- FUNC $7.04
- P/E Ratio
- INZY N/A
- FUNC $13.44
- Revenue Growth
- INZY N/A
- FUNC N/A
- 52 Week Low
- INZY $1.32
- FUNC $19.17
- 52 Week High
- INZY $7.80
- FUNC $36.49
- Technical
- Relative Strength Index (RSI)
- INZY 20.27
- FUNC 43.60
- Support Level
- INZY $1.32
- FUNC $31.24
- Resistance Level
- INZY $3.18
- FUNC $34.94
- Average True Range (ATR)
- INZY 0.27
- FUNC 0.67
- MACD
- INZY -0.15
- FUNC -0.03
- Stochastic Oscillator
- INZY 2.15
- FUNC 46.22
About INZY Inozyme Pharma Inc.
Inozyme Pharma Incclinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of diseases impacting the vasculature, soft tissue, and skeleton. The company is pursuing the development of therapeutics to address the underlying causes of these debilitating diseases. The company is focused on developing a novel therapy to treat the rare genetic diseases of ENPP1 and ABCC6 Deficiencies. The company product candidate, INZ-701, is a soluble, recombinant, genetically engineered, fusion protein that is designed to correct a defect in a pathway involving ENPP1 and ABCC6 Deficiencies.
About FUNC First United Corporation
First United Corp is active in the financial services domain. The scope of its offering includes checking, savings, money market deposit accounts and certificates of deposit, business loans, personal loans, mortgage loans and lines of credit extended to both individuals and businesses. In addition, it provides safe deposit and night depository facilities, insurance products and trust services. The bank also provides residential real estate construction loans to builders and individuals for single-family dwellings. It conducts business in two operating segments: Community Banking and Trust and Investment Services.